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Introduction 
On 28 November, JA-CHRODIS organised a workshop at the European Parliament with the 
aim of presenting the Joint Action CHRODIS (EU Joint Action on Chronic Diseases and 
promoting healthy ageing across the life-cycle) to European policy makers. The workshop 
had a special focus to display the achievements in the field of diabetes prevention and 
management, and presenting the CHRODIS Platform. The event was hosted by MEP Therese 
Comodini Cachia (EPP), co-chair of the European Parliament Diabetes Working Group. 
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Introductory remarks 
to the work of JA-
CHRODIS  
Chaired by JA-CHRODIS 
coordinator, Carlos Segovia 
(Instituto de Salud Carlos III), 
the event included 
introductory presentations 
from the leaders of each 
Work Package, with a special 
attention to the work on 
Type 2 Diabetes.  
The Work Package (WP) on Multimorbidity was presented by Graziano Onder who 
introduced the three main tasks of the WP6, consisting in the identification of targets of 
potential interventions for management of multi-morbid patients, revision of already 
existing care approaches and lastly, the development of a common model for 
multimorbidity management. Subsequently, Mr Onder presented three good clinical 
practices and introduced to the audience the 16 components of the common model. One of 
the identified components under the delivery system design is case manager (CM). Since CM 
competences are poorly defined at the European level, the Work Package also aimed at 
defining multi-morbidity case management training programmes. He concluded saying that 
pilot actions are needed to bring this theory into practice. 
The leader of WP4 (CHRODIS Platform), Enrique Bernal, took the opportunity to present 
the CHRODIS Platform, a resource centre in the form of an online tool where decision-
makers, caregivers, patients, and researchers across the EU can find and share the best 
knowledge on chronic diseases. A help desk is linked to the platform, providing services and 
advice on evaluation, implementation, and transfer of the submitted practices. Two experts 
in the field will review the submitted practices, while a third reviewer will make a final 
judgement. There is also a possibility to contact professionals who have submitted good 
practices in order to facilitate the transferability.  
The leader of WP5 (Health Promotion and disease prevention), Alexander Haarmann 
started his presentation by reiterating that chronic diseases can be prevented or delayed. To 
this end, WP5 looked at the wealth of good practices and experiences across Europe. In 
order to explain how they identified good practices, Mr Haarmann walked the audience 
through the process of the definition of good practice criteria. There are 10 criteria allowing 
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for comparison (weighted overall score) and identification of strengths and short-comings of 
practices in Health Promotion and Primary Prevention Interventions.  
WP5 has identified 41 good practices across the life cycle from different regions with 
different settings and varying degrees of complexity. Mr Haarmann also mentioned that six 
study visits in selected sites took place during the summer of 2016. By the end of the 2016, 
a recommendation report will be delivered. This report will include a description of success 
factors/barriers for transferring or scaling up a promising practice into a new context as well 
as guidance concerning what needs to be considered when planning, adapting and 
successfully implementing good practices. 
Marina Maggini, leader of WP7, presented diabetes as a case study on strengthening health 
care for people with chronic diseases. The work undertaken in this Work Package included 
mapping of existing National Diabetes Plans, improving coordination and cooperation 
between Member States, as well as sharing knowledge and expertise on diabetes 
prevention and care. The quality criteria and the recommendations arising from this work 
mainly targeted the improvement of early detection of diabetes, preventive interventions, 
and improvement of quality of care for people with diabetes.  
The recommendations could constitute a tool for decision makers, health care providers, 
patients and health care personnel to implement good practices, and to improve, monitor, 
and evaluate the quality of diabetes prevention and care. Those recommendations are 
general enough to be implemented in countries with different political, administrative, 
social and health care organizations. Lastly, the adoption of an agreed core set of quality 
criteria might help to decrease inequalities in health and to improve diabetes prevention 
and care within European countries. 
 
Good practices in health promotion and diabetes prevention 
After the WP7 introductory presentation, the Chair invited Jelka Zaletel and Luciana Costa to 
present good practices in health promotion and diabetes prevention.  
Jelka Zaletel, Slovenian National Institute of Public Health, presented the lessons learnt 
from the implementation of Slovenian National Diabetes Programme, which was debated at 
the European Parliament Diabetes Working Group in 2011.  
During the implementation of National Diabetes plan since 2010, in 2015, 8 national 
diabetes retinopathy screening centres were established and educational programmes for 
patients treated at primary care were developed and tested. In 2016, 654 primary care 
practices out of 890 have registered nurses (RNs) as care coordinators including for type 2 
diabetes. Furthermore, diabetes was used as a model disease to study performance of 
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healthcare system in Slovenia. Looking ahead, the development of the next National 
Diabetes Plan (2020-2030) will begin in 2017. 
During the Q&A session, reacting to the question from the audience regarding the budget 
allocated for the national plan, Ms Zaletel responded that Slovenia has a zero cost National 
Diabetes Plan spurred by a stakeholders’ initiative. The idea behind is not to use more 
money but to use it smartly or reallocate.  
Luciana Costa, researcher in the Department of Health Promotion and Prevention of Non-
communicable diseases at the Portuguese National Institute of Health, presented the 
diabetes prevention and screening in vulnerable populations in Lisbon area. The objective of 
this intervention was to promote health in vulnerable communities in the Lisbon 
Metropolitan Area, especially to detect undiagnosed diabetes and individuals at high-risk of 
diabetes. The screening was carried out outside of the national health system.  
The FINDRISK questionnaire was used for interviews to detect undiagnosed diabetes and 
individuals at-risk (58% women and 42 % men; mean age 57 years). All activities, such as 
health promotion and diabetes prevention sessions for the general public and training for 
health and social professionals, were implemented within the community with strong 
support from municipalities, healthcare providers, local NGOs. Results showed that out of 
11.712 people who carried out the risk assessment, 1.959 were identified as having 
high/very high risk of developing diabetes. In this group, around 20% of individuals had 
undiagnosed diabetes. The most valued factors for the population were both that 
awareness actions were free of charge and due to a close relationship with municipalities, 
healthcare providers and local NGOs, the stronger feeling of belonging to the community.  
According to Mr Bernal, this particular Portuguese good practice scores the highest among 
the evaluated practices submitted to the CHRODIS Platform. Responding to a question from 
the audience about the effect of the report received from the evaluators working behind 
the CHRODIS platform, Ms Costa said that they had their own evaluation process, yet an 
input from the experts outside of the system was very important to them. 
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Conclusions 
The event was concluded by Portuguese Member of European Parliament (MEP) Marisa 
Matias (GUE/NGL), co-chair of the European Parliament Diabetes Working Group, who 
welcomed requests and observations from experts and evidence gathered by JA-CHRODIS 
for future advocacy in the field of prevention and management of chronic diseases, 
especially action on diabetes. She mentioned, that with several other MEPs, they have re-
established EP Diabetes Working Group in 2009 and since then they have considerably 
contributed to the passing of the Resolution on Addressing the EU Diabetes Epidemic, a 
Written Declaration on diabetes to the European Commission and the European Council. 
MEP Matias concluded wishing best of luck to the JA-CHRODIS partners in their work and 
advocating a stronger collaboration at European level.  
 
 
 
